Skip to content

ISCT PDM Committee 2022 Particulate Survey - Service Providers

Particulate Survey- Service Providers


ISCT’s Process Development & Manufacturing Committee Particulate Working Group solicits your participation in the following survey to determine the current state of “Particulates in Cell & Gene Therapies”. Your feedback will allow us to build consensus and develop a framework for addressing pertinent issues as it relates to risk assessment and mitigation practices for particulate generation during cell and gene therapy manufacturing.

1.What is the nature of the company, lab, or institution you are working in?(Required.)
2.Where is your institute, lab or company located (City, State, Country)?(Required.)
3.Which position or title do you hold with your company, lab, or institution?(Required.)
4.What areas do you provide services or technologies to? (Choose all that apply)(Required.)
5.Which standards and guidance re: particulates are you aware of ? (Check all that apply)(Required.)
6.Have your customers brought concerns about particulates from tools, services and technologies (for example, secondary or tertiary packaging of single-use systems (SUS) you provide?(Required.)
7.Does particulate generation impact the services/tools/technologies you provide for cell and gene therapy customers?(Required.)
Current Progress,
0 of 21 answered